UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

P1085 Impact et rôle du liraglutide, un analogue du GPL-1 humain, dans le diabète de type-2 : le rationnel et le design de l’étude LEADER® évaluant les paramètres cardiovasculaires

Diabetes & metabolism, 2013-03, Vol.39, p.A51-A51

2013

Volltextzugriff (PDF)

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

The Lancet (British edition), 2009-07, Vol.374 (9683), p.39-47

2009

Volltextzugriff (PDF)

Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

Diabetic medicine, 2011-06, Vol.28 (6), p.715-723

2011

Volltextzugriff (PDF)

Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial

Diabetes, obesity & metabolism, 2011-01, Vol.13 (1), p.81-88

2011

Volltextzugriff (PDF)

Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure

Kidney international, 2000-08, Vol.58 (2), p.513-519

2000

Volltextzugriff (PDF)

Angiotensin I-converting enzyme gene polymorphisms : Relationship to nephropathy in patients with non-insulin dependent diabetes mellitus

Journal of the American Society of Nephrology, 1998-09, Vol.9 (9), p.1664-1669

1998

Volltextzugriff (PDF)

Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes

Canadian journal of diabetes, 2009, Vol.33 (3), p.255-256

2009

Volltextzugriff (PDF)

to: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428

Diabetologia, 2003-12, Vol.46 (12), p.1707-1708

2003

Volltextzugriff (PDF)

Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes

Nephrology, dialysis, transplantation, 2000-12, Vol.15 (12), p.1965-1970

2000

Volltextzugriff (PDF)

The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus

Diabetologia, 1999-01, Vol.42 (1), p.94-97

1999

Volltextzugriff (PDF)

Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure : Results of transmission/disequilibrium test

Journal of the American Society of Nephrology, 1999-10, Vol.10 (10), p.2120-2124

1999

Volltextzugriff (PDF)

Ultrasound picture of gastroesophageal junction in children with reflux disease

Medical science monitor, 2000-01, Vol.6 (1), p.96-99

2000

Volltextzugriff (PDF)

The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus

Diabetologia, 1998-10, Vol.41 (11), p.1304-1308

1998

Volltextzugriff (PDF)

G-Protein beta(3) subunit C825T variant, nephropathy and hypertension in patients with type 2 (Non-insulin-dependent) diabetes mellitus

American journal of nephrology, 2000-07, Vol.20 (4), p.305-310

2000

Volltextzugriff (PDF)

ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD)

Nephrology, dialysis, transplantation, 2007-05, Vol.22 (5), p.1483-1483

2007

Volltextzugriff (PDF)

Human SA gene Pst1 polymorphism and chronic renal failure: Results of the family‐based study

Nephrology, dialysis, transplantation, 2001-02, Vol.16 (2), p.387-390

2001

Volltextzugriff (PDF)

Ace gene insertion/deletion alleles: transmission from parents to dialysis and nondialysis patients with chronic renal failure

Nephron (2015), 2001-06, Vol.88 (2), p.187

2001

Volltextzugriff (PDF)

Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl

Diabetes, obesity & metabolism, 2011-01, Vol.13 (1), p.81-88

2011

Volltextzugriff (PDF)

Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes

Kidney international, 2001-02, Vol.59 (2), p.631-636

2001

Volltextzugriff (PDF)

Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension

Medical science monitor, 2000-05, Vol.6 (3), p.523-529

2000

Volltextzugriff (PDF)

Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group

Kidney international, 2000-08, Vol.58 (2), p.513-519

2000

Volltextzugriff (PDF)

PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH

Value in health, 2009, Vol.12 (3), p.A105-A105

2009

Volltextzugriff (PDF)

Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. The End-Stage Renal Disease Study Group

Journal of the American Society of Nephrology, 1999-10, Vol.10 (10), p.2120-2124

1999

Volltextzugriff (PDF)

G-Protein β3 Subunit C825T Variant, Nephropathy and Hypertension in Patients with Type 2 (Non-Insulin-Dependent) Diabetes mellitus

American journal of nephrology, 2000, Vol.20 (4), p.305-310

2000

Volltextzugriff (PDF)

Transmission of G-protein beta3 subunit C825T alleles to offspring affected with end-stage renal disease

American journal of nephrology, 2001-09, Vol.21 (5), p.368-372

2001

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(26)
Female
(20)
Male
(19)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Adult
(16)
Middle Aged
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Genotype
(13)
Urology & Nephrology
(13)
Polymorphism, Genetic
(12)
Diabetic Nephropathies - Genetics
(11)
Adolescent
(10)
Genetic Predisposition To Disease
(10)
Aged
(9)
Alleles
(9)
Kidney Failure, Chronic - Genetics
(9)
Diabetes Mellitus, Type 2 - Genetics
(7)
Nephrology. Urinary Tract Diseases
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P1085 Impact et rôle du liraglutide, un analogue du GPL-1 humain, dans le diabète de type-2 : le rationnel et le design de l’étude LEADER® évaluant les paramètres cardiovasculaires

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial

Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: Risk of chronic renal failure

Angiotensin I-converting enzyme gene polymorphisms : Relationship to nephropathy in patients with non-insulin dependent diabetes mellitus

Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes

to: Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC (2003) Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46:426-428

Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes

The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus

Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure : Results of transmission/disequilibrium test

Ultrasound picture of gastroesophageal junction in children with reflux disease

The C825T polymorphism in the human G-protein β3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus

G-Protein beta(3) subunit C825T variant, nephropathy and hypertension in patients with type 2 (Non-insulin-dependent) diabetes mellitus

ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD)

Human SA gene Pst1 polymorphism and chronic renal failure: Results of the family‐based study

Ace gene insertion/deletion alleles: transmission from parents to dialysis and nondialysis patients with chronic renal failure

Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, doubl

Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes

Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension

Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group

PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH

Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. The End-Stage Renal Disease Study Group

G-Protein β3 Subunit C825T Variant, Nephropathy and Hypertension in Patients with Type 2 (Non-Insulin-Dependent) Diabetes mellitus

Transmission of G-protein beta3 subunit C825T alleles to offspring affected with end-stage renal disease

Suchergebnisse filtern